Barbara Ruozi
0000-0002-2400-9910
11 papers found
Refreshing results…
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines
Tween® Preserves Enzyme Activity and Stability in PLGA Nanoparticles
Microfluidic Technology for the Production of Hybrid Nanomedicines
Nanomedicines for brain diseases: where we are and where we are going
Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity
Exploiting the Versatility of Cholesterol in Nanoparticles Formulation
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport
Missing publications? Search for publications with a matching author name.